Evithé Biotechnology’s Post

Jellatech Expands Operations with New 9,000 Sq Ft Facility Morrisville, NC - November 5, 2024 Jellatech, a leading innovator in sustainable protein production, is thrilled to announce the successful occupation of its new 9,000 sq ft facility designed for ongoing research and development. This facility, which is planned for GLP (Good Laboratory Practice) certification by 2026, marks a significant milestone in Jellatech’s mission to revolutionize the biotechnology landscape. The new facility will be the foundation for scaling up Jellatech’s bio-identical collagen manufacturing capabilities, with a focus on validation and enabling customers to enter pre-clinical trials. These efforts are crucial for establishing the groundwork needed for broad market adoption of collagen-based applications across various sectors. Equipped with advanced bioreactors and specialized labs, the facility allows Jellatech to accelerate the development of high-value proteins, optimize cell line development, and meet stringent regulatory requirements in the biomedical and pharmaceutical industries. “Our new facility represents a leap forward in our ability to deliver high-quality, consistent, and ethically produced proteins for human health and longevity applications,” said Stephanie Michelsen, CEO of Jellatech. “This move not only significantly increases our production capacity but also reinforces our commitment to setting new standards in sustainability, innovation and cutting edge biotechnology.” The facility, located in Morrisville, NC, will also serve as a hub for partnerships with industry leaders, enabling collaborative research and development aimed at advancing the next generation of biostimulatory and regenerative healthcare solutions. About Jellatech: Jellatech is at the forefront of biotechnology, specializing in sustainable, bio-identical protein production. With a focus on ethical, scalable, and environmentally friendly processes, Jellatech provides innovative solutions for industries ranging from biomedical to food and beverage. For more information, visit www.jellatech.com or contact hello@jellatech.com. #Jellatech #BiotechInnovation #HumanCollagen #SustainableBiotech #ProteinProduction #NewFacility #RDBreakthroughs #PreClinicalTrials #FutureOfBiotech #CollagenRevolution #GLPStandards

🚀 Exclusive Interview with Jeremy Elser, CEO of Ship of Theseus 🌱 (EWMA Innovation Competition Winner 2024) Excited to share our conversation with Jeremy Elser, founder and CEO of Ship of Theseus, a pioneering biotechnology company. Jeremy recently won the EWMA Innovation Competition, and in this interview, he shares insights into his journey, their groundbreaking work in wound care, and the future of Ship of Theseus. Key takeaways from the interview: 🌍 Ship of Theseus' mission: Leveraging cutting-edge biotechnology to improve wound healing through transcription factor-based treatments. 🏆 Impact of winning the EWMA Innovation Award: Boosting the company's recognition and opening doors to new partnerships and collaborations. 🔬 Exciting pipeline: Their lead product, Trireme, is set to enter clinical trials by 2025. Don’t miss this insightful conversation! 🎥 https://lnkd.in/d8-PBi82 #biotechnology #innovation #woundcare #ShipOfTheseus #biotech #EWMAInnovationCompetition #healthtech #clinicaltrials #EWMAInnovationAlliance

Regal Grange Investment Group portfolio company (i.e., IPECO Pty Ltd) is pleased to announce that Aginnovation | Seed Improvement Technologies (AGI) has acquired a majority stake in Activate Ag Labs (AAL). As a result of this transaction, IPECO now owns minority stake in Activate Ag Labs. Activate Ag Labs is a global business established as a profit-for-purpose organization where its primary goal is to support and serve various commercial entities through R&D activities, including IP licensing, project work, services, and consulting. This strategic acquisition & alliance will not only strengthen IPECO-AGI partnership but will also enhance Aginnovation | Seed Improvement Technologies product portfolio, expand global presence, and further drive innovation across seed enhancement portfolio that will serve the best interest of all End User Customers across the globe. #R&D #seedtechnology #growth

Our Better Biotech Growth webinar series kicks off this September! Join Simone Seiter and Kevin Baruzzi as they reveal how to transform scientific innovations into market successes. Learn to create a winning product strategy and integrate key insights from various stakeholders to achieve commercial excellence. Don't miss this opportunity! Register now: skp.link/rw7l #BetterBiotechGrowth #Biotech #CommercialExcellence #SimonKucher #BiotechGrowth

Our Better Biotech Growth webinar series kicks off this September! Join Simone Seiter and Kevin Baruzzi as they reveal how to transform scientific innovations into market successes. Learn to create a winning product strategy and integrate key insights from various stakeholders to achieve commercial excellence. Don't miss this opportunity! Register now: skp.link/rw7l #BetterBiotechGrowth #Biotech #CommercialExcellence #SimonKucher #BiotechGrowth

Did you know that we have an official Biomerics YouTube channel? We regularly upload videos featuring engineers, leadership and other employees from across our global organization. These experts in their fields discuss various topics, including manufacturing processes, thought leadership, technical expertise, community involvement and ways we live our values as a Biomerics family. Check out our channel and hit the subscribe button to be notified every time we upload a new video! #biomerics

🌟 Uses of SYNTHIA™ Retrosynthesis Software and how useful is it by KPIs at GSK! 🌟 🔬 John Jin Lim from GSK provides an insightful overview of the multifaceted applications of SYNTHIA™ within the organization, shedding light on its pivotal role in departmental brainstorms, chemistry roundtable activities, project support, and route intent and selection. 🧠 The integration of SYNTHIA™ in departmental brainstorms and chemistry roundtable activities has significantly enhanced idea generation, with an impressive 86% of chemical development users reporting time savings of at least an hour per user when utilizing SYNTHIA™. This remarkable efficiency gain underscores the tangible impact of SYNTHIA™ in streamlining the brainstorming process and accelerating idea generation. 🔍 Furthermore, the quality of SYNTHIA's output has been evaluated through the ranking of top ideas by project leaders. In 2020, SYNTHIA's suggestions were ranked in the top three for one brainstorm, and in 2021, this success rate has soared, with SYNTHIA's suggestions securing a place in the top three for all three brainstorms conducted so far. This achievement not only meets but exceeds the KPI for 2021, highlighting the consistent value and impact of SYNTHIA's contributions to idea generation and project development. 📈 GSK's benchmark of ensuring that at least 20% of the total ideas be CASD-generated to ensure disconnection diversity and comprehensive coverage of chemical space is a testament to the organization's commitment to leveraging innovative tools like SYNTHIA™ to drive creativity and exploration in chemical development. 🚀 The success stories shared by John Jin Lim underscore the transformative influence of SYNTHIA™ on idea generation, project support, and route intent and selection at GSK, setting new standards for efficiency, quality, and innovation in chemical development. 🔗 Explore the full webinar to gain deeper insights into how SYNTHIA™ is reshaping the landscape of brainstorming and idea generation at GSK, propelling the organization toward unparalleled productivity and groundbreaking discoveries. https://lnkd.in/ekmhpiSs #ChemicalDevelopment #Innovation #GSK #SYNTHIA #Retrosynthesis #Brainstorming #IdeaGeneration #ChemicalEngineering #WebinarInsights #TeamMerck

🌟 Uses of SYNTHIA™ Retrosynthesis Software and how useful is it by KPIs at GSK! 🌟 🔬 John Jin Lim from GSK provides an insightful overview of the multifaceted applications of SYNTHIA™ within the organization, shedding light on its pivotal role in departmental brainstorms, chemistry roundtable activities, project support, and route intent and selection. 🧠 The integration of SYNTHIA™ in departmental brainstorms and chemistry roundtable activities has significantly enhanced idea generation, with an impressive 86% of chemical development users reporting time savings of at least an hour per user when utilizing SYNTHIA™. This remarkable efficiency gain underscores the tangible impact of SYNTHIA™ in streamlining the brainstorming process and accelerating idea generation. 🔍 Furthermore, the quality of SYNTHIA's output has been evaluated through the ranking of top ideas by project leaders. In 2020, SYNTHIA's suggestions were ranked in the top three for one brainstorm, and in 2021, this success rate has soared, with SYNTHIA's suggestions securing a place in the top three for all three brainstorms conducted so far. This achievement not only meets but exceeds the KPI for 2021, highlighting the consistent value and impact of SYNTHIA's contributions to idea generation and project development. 📈 GSK's benchmark of ensuring that at least 20% of the total ideas be CASD-generated to ensure disconnection diversity and comprehensive coverage of chemical space is a testament to the organization's commitment to leveraging innovative tools like SYNTHIA™ to drive creativity and exploration in chemical development. 🚀 The success stories shared by John Jin Lim underscore the transformative influence of SYNTHIA™ on idea generation, project support, and route intent and selection at GSK, setting new standards for efficiency, quality, and innovation in chemical development. 🔗 Explore the full webinar to gain deeper insights into how SYNTHIA™ is reshaping the landscape of brainstorming and idea generation at GSK, propelling the organization toward unparalleled productivity and groundbreaking discoveries. https://lnkd.in/exPrUSib #ChemicalDevelopment #Innovation #GSK #SYNTHIA #Retrosynthesis #Brainstorming #IdeaGeneration #ChemicalEngineering #WebinarInsights #TeamMerck

Our Better Biotech Growth webinar series kicks off this September! Join Simone Seiter and Kevin Baruzzi as they reveal how to transform scientific innovations into market successes. Learn to create a winning product strategy and integrate key insights from various stakeholders to achieve commercial excellence. Don't miss this opportunity! Register now: skp.link/rw7l #BetterBiotechGrowth #Biotech #CommercialExcellence #SimonKucher #BiotechGrowth